News und Analysen
Do These 5 Words From Pfizer Mean Trouble for Novavax?
This vaccination season could be a key moment for vaccine makers and investors. That's because it's offering us a first glimpse into the future coronavirus vaccine revenue opportunity. Companies
Better Dividend Stock: Walgreens Boots Alliance vs. UnitedHealth Group
If you're looking for income-generating investments to fuel your retirement dreams, it's hard to go wrong with dividend-paying stocks in the healthcare sector. After all, people need medical care
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
The three most prominent themes in stock investing this year have been artificial intelligence (AI), weight-loss care, and profitability. Companies with strong profitability and/or ties to AI and
2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now
Pfizer (NYSE: PFE) and Gilead Sciences (NASDAQ: GILD) are two of the world's largest and most prominent drugmakers, not that this has somehow prevented investors from selling off their shares this
Is Vertex Pharmaceuticals Stock a Buy Now?
Vertex Pharmaceuticals (NASDAQ: VRTX) is a growing business that generates billions in annual profit and has some incredible opportunities ahead. It's easy to see why investors are bullish on the
3 Dividend Growth Stocks You Can Buy and Hold Forever
What's better than a stock that pays dividends? A stock with growing dividends and a business that's built for long-term success.
Three Motley Fool contributors identified stocks they think fit the
Why UnitedHealth Group Stock Jumped Today
Shares of UnitedHealth Group (NYSE: UNH) climbed as much as 3.6% early Friday, then settled to trade up around 2.3% as of 2:30 p.m. ET after the the healthcare benefits company announced strong
UnitedHealth Group (UNH) Q3 2023 Earnings Call Transcript
UnitedHealth Group (NYSE: UNH)Q3 2023 Earnings CallOct 13, 2023, 8:45 a.m. ET
Operator
Source Fool.com
Why Vertex Energy Stock Popped 15% Today
Shares of Vertex Energy (NASDAQ: VTNR) zoomed on Friday and were trading 10% higher as of 11 a.m. ET after the company projected better-than-expected throughput volumes for its third quarter. The
Viatris Just Sold Off 3 Key Segments. Is It Still a Buy?
On Oct. 1, Viatris (NASDAQ: VTRS) made an announcement that's sure to shake up its fortunes. It's divesting nearly all of its over-the-counter (OTC) medicines, its entire women's healthcare segment
Is This Dividend Stock a Screaming Buy After Its Latest Acquisition?
Large companies often turn to acquisitions to jump-start revenue and earnings growth or to speed up research and development, among other reasons. However, these moves aren't always successful, so
Is Amgen Stock a Buy Now?
The U.S. Federal Trade Commission (FTC) allowed Amgen's (NASDAQ: AMGN) purchase of Horizon Therapeutics to go through last month and the company announced the closing of the deal in a press release
Why Shares of Sharecare Are Soaring on Wednesday
Shares of Sharecare (NASDAQ: SHCR) were up more than 26% as of 2 p.m. ET on Wednesday after the digital healthcare company said it had received a proposal from a private equity firm to buy the
3 Reasons to Buy Abbott Laboratories Stock
Medical device giant Abbott Laboratories (NYSE: ABT) hasn't performed well in the past year. The company has had to deal with several issues that affected its results and its public image, notably
2 Healthcare Dividend Stocks You'd Regret Not Buying on the Dip
For income-seeking investors, the only thing better than a solid dividend stock is a beaten-down one whose shares can be bought on the dip. And while the market has largely recovered this year, some
Is Editas Stock a Buy Now?
Gene editing is one of the most revolutionary trends in modern medicine. The potential to swap out a person's genes to eliminate and prevent diseases is here, and investors are keenly looking at
3 No-Brainer Growth Stocks to Buy in October
Smart investors are continually looking for new investment ideas. Sometimes, those ideas are so good that they're hard to pass up.
Three Motley Fool contributors think they've picked some stocks
Should You Load Up On This 1 Dividend Stock?
There are excellent reasons to invest in dividend stocks beyond their regular payouts. Growing a dividend requires companies to deliver solid financial results regularly, and the longer a
Better Growth Stock: Novo Nordisk vs. Pfizer
Pfizer (NYSE: PFE) and Novo Nordisk (NYSE: NVO) are two top pharmaceutical companies that are pursuing growth opportunities. Pfizer is looking to build up and diversify its business as its COVID
This Market-Beating Stock Just Gave Investors More Reasons to Invest
Investing wisdom tells us to buy low, but what exactly constitutes a "low" point? Consider the case of Regeneron (NASDAQ: REGN), a biotech company that has beaten the market in recent years. Despite
Where Will UnitedHealth Group Stock Be in 5 Years?
UnitedHealth Group (NYSE: UNH) is one of the largest healthcare companies in the world. It's already a top health insurer in the U.S., but that doesn't mean the company isn't working to be even
Pharma Giants Combine Forces to Fight New M&A Rules
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.
Meet the
2 High-Yield Dividend Stocks to Buy in October
High-yield dividend stocks are a powerful way to boost a portfolio's annual performance. By reinvesting the dividend and regularly buying more shares, these stocks can produce impressive returns
3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years
If you're investing in a dividend stock, there's more than just the yield and the payout ratio to consider. It's also important to look at dividend increases -- whether the company has been making
Is Pfizer Stock a Buy Now?
Pfizer (NYSE: PFE) sells a wide variety of medicines across treatment areas such as autoimmune diseases and oncology. But it probably is most known for its leading coronavirus vaccine, which helped